Jim Hartman | Food Safety | Best Researcher Award

Published on by Global Academic Awards

Mr. Jim Hartman | Food Safety | Best Researcher Award

Mr. Jim Hartman, United States

Jim Hartman, a retired Public Health Sanitarian, holds a Master’s in Preventive Medicine and a Bachelor’s in Microbiology from The Ohio State University 🎓. With expertise in foodborne illness epidemiology, mold inspections, and childhood lead poisoning prevention, he has made significant contributions to public health. Jim is a Registered Sanitarian (Ohio R.S. # 1372) and an active member of NEHA and IAFP 🤝. His research includes predictive models for food safety and surveillance systems, with publications in Food Protection Trends 📚. Jim’s dedication to health and safety underscores his impactful career in environmental health.

 

Publication Profile

Orcid

Education and Affiliations 🎓🤝

Jim Hartman earned a Master of Science in Preventive Medicine from The Ohio State University, specializing in epidemiology and public health 🌟. His coursework included biostatistics, environmental health, and health economics, with a thesis using predictive modeling to identify food service code violations linked to foodborne illness 🍴. He also holds a Bachelor of Science in Microbiology, focusing on food microbiology 🧫. An active member of the National Environmental Health Association (NEHA) and the International Association for Food Protection (IAFP) 🌍, Jim stays engaged in professional development. Additionally, he is a dedicated Masters swimmer, showcasing his commitment to wellness 🏊‍♂️.

 

 

Skills and Qualifications 🛠️

Jim Hartman possesses extensive expertise in public health, with a deep understanding of Ohio and Columbus public health sanitary regulations 🏙️. As a Registered Sanitarian (Ohio R.S. # 1372), he has demonstrated proficiency in ensuring compliance with health and safety standards. His qualifications reflect a strong commitment to public health and environmental safety, contributing to his impactful career in areas such as food facility inspections, mold assessments, and childhood lead poisoning prevention. Jim’s skills underscore his ability to address complex public health challenges effectively, making him a respected professional in the field of environmental health 🌍.

 

Employment History 👨‍💼

Jim Hartman served as a Public Health Sanitarian at Columbus Public Health (formerly the Columbus Health Department) before retiring 🌟. His most recent role focused on the Healthy Homes Program, where he conducted inspections related to childhood lead poisoning, asthma control, and mold hazards 🏠. Previously, he spent many years ensuring public safety through facility inspections and critical control point evaluations of food service operations, grocery stores, and bakeries 🛒🍞. Jim’s dedication to public health and environmental safety has left a lasting impact on the community, showcasing his commitment to improving health standards and living conditions 🌍.

 

Research Focus

Jim Hartman’s research focuses on food safety, public health, and epidemiology. His notable work, Predictive Models for Food Code Violations, published in Food Protection Trends (2020), highlights his expertise in using data-driven approaches to enhance food safety protocols 📊. By developing models to predict food code violations, his research addresses critical gaps in preventing foodborne illnesses 🦠. This aligns with his broader interests in environmental health and public health regulations. Jim’s contributions showcase his dedication to improving food safety standards and ensuring public health through innovative and practical solutions 🚦.

 

Publication Top Notes  

📄 “Predictive Models for Food Code Violations” – Food Protection Trends, 2020 🗓️ | Authored by Jim Hartman ✍️

 

 

 

Asal Katebi | Infectious disease | Best Researcher Award

Published on by Global Academic Awards

Dr. Asal Katebi | Infectious disease | Best Researcher Award

Medical Immunology, Pasteur Institute of Iran

Asal Katebi, Ph.D., is an Assistant Professor at the Pasteur Institute of Iran, specializing in Medical Immunology. Her research focuses on developing therapeutic vaccines for infectious diseases like leishmaniasis using nanoparticle formulations and TLR agonists. She holds a Ph.D. in Medical Immunology from Isfahan University of Medical Sciences and has extensive experience in molecular biology and immunotherapy.

Profile

Google Scholar

 

📚 Education:

Asal Katebi completed her Ph.D. in Medical Immunology at Isfahan University of Medical Sciences, where she conducted research on therapeutic vaccines for leishmaniasis. She also holds an M.Sc. in Medical Immunology from Tehran University of Medical Sciences and a B.Sc. in Microbiology from Islamic Azad University, North Tehran Branch.

👩‍💼 Experience:

Dr. Katebi’s professional journey includes significant roles at the Pasteur Institute of Iran, where she conducts research, mentors students, and teaches courses in immunology. She has expertise in molecular immunology, nanoparticle preparation, cell culture techniques, and has contributed to numerous research projects aimed at combating infectious diseases.

🔬 Research Interests:

Her research interests span molecular immunology and immunotherapy, focusing on vaccine development against leishmaniasis. Dr. Katebi is particularly interested in nanoparticle-based delivery systems, TLR agonists, and the immunomodulatory effects of extracellular vesicles derived from parasites.

🏆 Awards:

Asal Katebi has received recognition for her contributions to immunological research, including awards for her presentations at international congresses. Notably, she was honored for her work on the SLA-R848-Pam3CSK4 combination as a therapeutic vaccine for cutaneous leishmaniasis.

📄 Publications:

Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection – Molecular Immunology, 2015

Leishmania tarentolae secreting PpSP15 and CpG motifs protects against Leishmania major infection – European Journal of Immunology, 2019

Combinatorial delivery of antigen and TLR agonists via PLGA nanoparticles modulates Leishmania major-infected macrophages – Biomedicine & Pharmacotherapy, 2021